Kewaunee Scientific Corporation Insider Trading

KEQU

Last 12 months

Insiders sold 293K and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Chief Financial Officer Donald T. Gardner III sold 75K on Jan 6, 17% of their stake, outside a plan. The last open-market buy by an executive or director was in Apr 2025.

Net open-market

−293K

0 buys · 6 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 2

executives and directors

Last open-market buy

Apr 2025

Apr 4, 2025

Get an email when KEQU's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jan 7	Thomas David Hull III President, CEO	SoldNo plan	2,177	$37.50	82K	6.2%	Form 4
Jan 6	Donald T. Gardner III Chief Financial Officer	SoldNo plan	2,000	$37.57	75K	17%	Form 4
Dec 30, 2025 – Dec 31, 2025	Thomas David Hull III President, CEO	SoldNo plan 2 parts	658	$37.67 average	25K	1.8%	Form 4
Dec 29, 2025	Thomas David Hull III President, CEO	SoldNo plan	884	$38.01	34K	2.4%	Form 4
Dec 22, 2025	Thomas David Hull III President, CEO	SoldNo plan	1,000	$39.00	39K	2.7%	Form 4
Dec 17, 2025	Thomas David Hull III President, CEO	SoldNo plan	1,000	$39.00	39K	2.6%	Form 4
Oct 9, 2025	Donald T. Gardner III Chief Financial Officer	SoldNo plan	3,000	$42.76	128K	21%	Form 4
Oct 2, 2025	Elizabeth D Phillips VP - Human Resources	SoldNo plan 2 parts	6,880	$43.20 average	297K	45%	Form 4
Oct 1, 2025	Thomas David Hull III President, CEO	SoldNo plan	1,000	$43.09	43K	2.5%	Form 4
Sep 29, 2025	Thomas David Hull III President, CEO	SoldNo plan	1,854	$43.42	81K	4.5%	Form 4
Sep 23, 2025 – Sep 24, 2025	Thomas David Hull III President, CEO	SoldNo plan 2 parts	1,721	$43.78 average	75K	4.0%	Form 4
Sep 18, 2025 – Sep 19, 2025	Thomas David Hull III President, CEO	SoldNo plan 2 parts	1,425	$45.64 average	65K	3.2%	Form 4
Jul 24, 2025	Donald T. Gardner III Chief Financial Officer	SoldNo plan 2 parts	3,000	$58.59 average	176K	17%	Form 4
Apr 14, 2025	Thomas David Hull III President, CEO	SoldNo plan	1,844	$32.44	60K	4.9%	Form 4
Apr 9, 2025 – Apr 10, 2025	Donald T. Gardner III Chief Financial Officer	SoldNo plan 3 parts	4,000	$37.11 average	148K	22%	Form 4
Apr 4, 2025	Keith M Gehl Director	Bought	1,000	$35.00	35K	5.7%	Form 4
Mar 26, 2025	Donald T. Gardner III Chief Financial Officer	SoldNo plan 3 parts	3,000	$40.01 average	120K	14%	Form 4
Mar 21, 2025 – Mar 24, 2025	Thomas David Hull III President, CEO	SoldNo plan 3 parts	3,213	$45.82 average	147K	7.8%	Form 4
Mar 24, 2025	Keith M Gehl Director	Bought	500	$45.00	23K	2.9%	Form 4
Mar 18, 2025	Keith M Gehl Director	Bought	403	$49.00	20K	2.4%	Form 4
Jan 10, 2025	Donald T. Gardner III Chief Financial Officer	SoldNo plan	1,257	$59.26	74K	5.6%	Form 4
Jan 10, 2025	Thomas David Hull III President, CEO	SoldNo plan	1,368	$60.08	82K	3.2%	Form 4
Dec 30, 2024	Ryan S. Noble VP-Sales & Marketing-Americas	SoldNo plan	1,500	$66.00	99K	11%	Form 4
Dec 30, 2024	Douglas J. Batdorff VP of Manufacturing Operations	SoldNo plan	3,470	$65.50	227K	41%	Form 4
Dec 26, 2024	Thomas David Hull III President, CEO	SoldNo plan	2,000	$63.01	126K	4.5%	Form 4
Dec 24, 2024	Donald T. Gardner III Chief Financial Officer	SoldNo plan 5 parts	2,049	$58.19 average	119K	8.3%	Form 4
Dec 17, 2024	Elizabeth D Phillips VP - Human Resources	SoldNo plan	1,850	$54.17	100K	12%	Form 4

Jan 7No plan
Thomas David Hull III
President, CEO · sold 2,177 at $37.50
82K
6.2% of stake
Jan 6No plan
Donald T. Gardner III
Chief Financial Officer · sold 2,000 at $37.57
75K
17% of stake
Dec 30, 2025 – Dec 31, 2025No plan
Thomas David Hull III
President, CEO · sold 658 at avg $37.67
25K
1.8% of stake
Dec 29, 2025No plan
Thomas David Hull III
President, CEO · sold 884 at $38.01
34K
2.4% of stake
Dec 22, 2025No plan
Thomas David Hull III
President, CEO · sold 1,000 at $39.00
39K
2.7% of stake
Dec 17, 2025No plan
Thomas David Hull III
President, CEO · sold 1,000 at $39.00
39K
2.6% of stake
Oct 9, 2025No plan
Donald T. Gardner III
Chief Financial Officer · sold 3,000 at $42.76
128K
21% of stake
Oct 2, 2025No plan
Elizabeth D Phillips
VP - Human Resources · sold 6,880 at avg $43.20
297K
45% of stake
Oct 1, 2025No plan
Thomas David Hull III
President, CEO · sold 1,000 at $43.09
43K
2.5% of stake
Sep 29, 2025No plan
Thomas David Hull III
President, CEO · sold 1,854 at $43.42
81K
4.5% of stake
Sep 23, 2025 – Sep 24, 2025No plan
Thomas David Hull III
President, CEO · sold 1,721 at avg $43.78
75K
4.0% of stake
Sep 18, 2025 – Sep 19, 2025No plan
Thomas David Hull III
President, CEO · sold 1,425 at avg $45.64
65K
3.2% of stake
Jul 24, 2025No plan
Donald T. Gardner III
Chief Financial Officer · sold 3,000 at avg $58.59
176K
17% of stake
Apr 14, 2025No plan
Thomas David Hull III
President, CEO · sold 1,844 at $32.44
60K
4.9% of stake
Apr 9, 2025 – Apr 10, 2025No plan
Donald T. Gardner III
Chief Financial Officer · sold 4,000 at avg $37.11
148K
22% of stake
Apr 4, 2025
Keith M Gehl
Director · bought 1,000 at $35.00
35K
5.7% of stake
Mar 26, 2025No plan
Donald T. Gardner III
Chief Financial Officer · sold 3,000 at avg $40.01
120K
14% of stake
Mar 21, 2025 – Mar 24, 2025No plan
Thomas David Hull III
President, CEO · sold 3,213 at avg $45.82
147K
7.8% of stake
Mar 24, 2025
Keith M Gehl
Director · bought 500 at $45.00
23K
2.9% of stake
Mar 18, 2025
Keith M Gehl
Director · bought 403 at $49.00
20K
2.4% of stake
Jan 10, 2025No plan
Donald T. Gardner III
Chief Financial Officer · sold 1,257 at $59.26
74K
5.6% of stake
Jan 10, 2025No plan
Thomas David Hull III
President, CEO · sold 1,368 at $60.08
82K
3.2% of stake
Dec 30, 2024No plan
Ryan S. Noble
VP-Sales & Marketing-Americas · sold 1,500 at $66.00
99K
11% of stake
Dec 30, 2024No plan
Douglas J. Batdorff
VP of Manufacturing Operations · sold 3,470 at $65.50
227K
41% of stake
Dec 26, 2024No plan
Thomas David Hull III
President, CEO · sold 2,000 at $63.01
126K
4.5% of stake
Dec 24, 2024No plan
Donald T. Gardner III
Chief Financial Officer · sold 2,049 at avg $58.19
119K
8.3% of stake
Dec 17, 2024No plan
Elizabeth D Phillips
VP - Human Resources · sold 1,850 at $54.17
100K
12% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch KEQU, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Laboratory Apparatus & Furniture · Pick stocks to compare with KEQU

CompareIntrinsic value

MLABMesa Laboratories Inc.

$126.19+0.57%59

TRNSTranscat Inc.

$108.13+20.79%40

CTKBCytek Biosciences, Inc.

$5.88-1.34%50

HURCHurco Companies, Inc.

$21.24-3.63%43

PACBPacific Biosciences of California, Inc.

$2.55+4.51%26

QTRXQuanterix Corporation

$3.04+3.40%24

INTTIntest Corporation

$14.00-4.63%4

SYPRSypris Solutions Inc.

$1.27-5.22%3

Held by ETFs

KEQU is in 4 US ETFs. The largest of them, with KEQU's weight in each:

Spot a number that looks wrong? Check it in KEQU's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing KEQU

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.